Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
Citalopram appears to be effective in reducing agitation in Alzheimer's Disease. However, side-effects were significant, with patients on citalopram experiencing worsened cognition and QT interval prolongation.
